Understanding, Predicting, Preventing, and Treating Ventricular Arrhythmias: Pushing Sudden Death Into Overtime

John L. Sapp; Andrew Krahn; William G. Stevenson; Carol Ann Remme; Francois Philippon; Stanley Nattel

doi:10.1016/j.cjca.2022.02.013

Understanding, Predicting, Preventing, and Treating Ventricular Arrhythmias: Pushing Sudden Death Into Overtime

John L. Sapp, Andrew Krahn, William G. Stevenson, Carol Ann Remme, Francois Philippon, Stanley Nattel

Medicine

Producción científica: Contribución a una revista › Editorial › revisión exhaustiva

3 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	414-417
Número de páginas	4
Publicación	Canadian Journal of Cardiology
Volumen	38
N.º	4
DOI	https://doi.org/10.1016/j.cjca.2022.02.013
Estado	Published - abr. 2022

Nota bibliográfica

Funding Information:
J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 “Method for ablating with needle electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc., Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose.

Funding Information:
The authors have no funding sources to declare. J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 “Method for ablating with needle electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc. Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose.

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

PubMed: MeSH publication types

Editorial

Acceder al documento

10.1016/j.cjca.2022.02.013

Otros archivos y enlaces

Citar esto

@article{ca08f904fa294c98a450994809993a93,

title = "Understanding, Predicting, Preventing, and Treating Ventricular Arrhythmias: Pushing Sudden Death Into Overtime",

author = "Sapp, {John L.} and Andrew Krahn and Stevenson, {William G.} and Remme, {Carol Ann} and Francois Philippon and Stanley Nattel",

note = "Funding Information: J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 “Method for ablating with needle electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc., Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose. Funding Information: The authors have no funding sources to declare. J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 “Method for ablating with needle electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc. Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose.",

year = "2022",

month = apr,

doi = "10.1016/j.cjca.2022.02.013",

language = "English",

volume = "38",

pages = "414--417",

journal = "Canadian Journal of Cardiology",

issn = "0828-282X",

publisher = "Pulsus Group Inc.",

number = "4",

}

TY - JOUR

T1 - Understanding, Predicting, Preventing, and Treating Ventricular Arrhythmias

T2 - Pushing Sudden Death Into Overtime

AU - Sapp, John L.

AU - Krahn, Andrew

AU - Stevenson, William G.

AU - Remme, Carol Ann

AU - Philippon, Francois

AU - Nattel, Stanley

N1 - Funding Information: J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 “Method for ablating with needle electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc., Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose. Funding Information: The authors have no funding sources to declare. J.L.S.: coholder of needle ablation catheter patent, rights assigned to Brigham and Women's Hospital, investigator initiated research grant funding: Biosense Webster, Abbott; Honoraria from Medtronic, Abbott, Biosense Webster. W.G.S.: co-holder of US patent #7207989 “Method for ablating with needle electrode” patent for irrigated needle ablation that is consigned to Brigham Hospital. To date no royalties have been received. He has received speaking honoraria from Abbott Medical, Boston Scientific, Inc. Johnson and Johnson, Biotronik, and Medtronic, Inc and consulting fee from Abiomed. Research funding from Thermedical. The other authors have no conflicts of interest to disclose.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85125652092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125652092&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2022.02.013

DO - 10.1016/j.cjca.2022.02.013

M3 - Editorial

C2 - 35183676

AN - SCOPUS:85125652092

SN - 0828-282X

VL - 38

SP - 414

EP - 417

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

IS - 4

ER -